Article
Overexpression of IL-7 enhances cisplatin resistance in glioma
1 May 2012
Abstract excerpt
Cisplatin is one of the most commonly used chemotherapeutic agents for glioma patients. In this study, array comparative genomic hybridization (aCGH) was used to identify genes associated with cisplatin resistance in a human glioma cell line. The cisplatin-resistant U251/CP2 cell line was derived by stepwise selection using cisplatin. The genetic aberrations of the U251 parental cell line and the U251/CP2 cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
